US Equity
XENE
— XENON PHARMACEUTICALS INC.Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurological disorders, including epilepsy.
💰 Market cap: $6.36B📍 3650 Gilmore Way, VANCOUVER, BC, V5G 4W8 CA🏷️ Biotechnology & Medical Research💵 Previous close: $65.42🔢 7,564 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $65.42 |
| 2026-07-23 | $65.42 |
| 2026-07-22 | $66.18 |
| 2026-07-21 | $66.74 |
| 2026-07-20 | $66.04 |
| 2026-07-17 | $68.26 |
| 2026-07-16 | $66.98 |
| 2026-07-15 | $67.71 |
| 2026-07-14 | $67.30 |
| 2026-07-13 | $67.72 |
| 2026-07-10 | $68.92 |
| 2026-07-09 | $70.96 |
| 2026-07-08 | $69.95 |
| 2026-07-07 | $63.37 |
| 2026-07-06 | $60.54 |
| 2026-07-02 | $60.96 |
| 2026-07-01 | $60.30 |
| 2026-06-30 | $60.36 |
| 2026-06-29 | $60.13 |
| 2026-06-26 | $59.74 |
| 2026-06-25 | $56.78 |
| 2026-06-24 | $55.58 |
| 2026-06-23 | $54.61 |
| 2026-06-22 | $54.79 |
| 2026-06-18 | $52.91 |
| 2026-06-17 | $53.20 |
| 2026-06-16 | $51.99 |
| 2026-06-15 | $52.40 |
| 2026-06-12 | $52.10 |
| 2026-06-11 | $52.19 |
| 2026-06-10 | $51.34 |
| 2026-06-09 | $52.79 |
| 2026-06-08 | $51.21 |
| 2026-06-05 | $51.73 |
| 2026-06-04 | $52.99 |
| 2026-06-03 | $53.46 |
| 2026-06-02 | $52.30 |
| 2026-06-01 | $53.41 |
| 2026-05-29 | $54.73 |
| 2026-05-28 | $54.79 |
| 2026-05-27 | $53.90 |
| 2026-05-26 | $53.98 |
| 2026-05-22 | $54.17 |
| 2026-05-21 | $54.12 |
| 2026-05-20 | $54.68 |
| 2026-05-19 | $54.05 |
| 2026-05-18 | $53.71 |
| 2026-05-15 | $54.39 |
| 2026-05-14 | $56.00 |
| 2026-05-13 | $55.88 |
| 2026-05-12 | $55.00 |
| 2026-05-11 | $55.78 |
| 2026-05-08 | $56.44 |
| 2026-05-07 | $56.00 |
| 2026-05-06 | $58.59 |
| 2026-05-05 | $57.71 |
| 2026-05-04 | $57.40 |
| 2026-05-01 | $56.13 |
| 2026-04-30 | $56.04 |
| 2026-04-29 | $55.75 |
| 2026-04-28 | $54.53 |